Refanidis Ioannis - University of Macedonia
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine
Efficacy of 5-FU or Oxaliplatin Monotherapy over Combination Therapy in Colorectal Cancer
WCC-2022
BIT's 13th Annual World Cancer Congress-2020（WCC-2021）
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine
Stem Cell 2019 - American College for Advancement in Medicine (ACAM)
Open 2015 by Clare Hamman - Issuu
Abstracts - 2021 - Transplant International - Wiley Online Library
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine
ECTS Guide
Stem Cell 2019 - American College for Advancement in Medicine (ACAM)
PDF) Efficacy of 5-FU or Oxaliplatin Monotherapy over Combination Therapy in Colorectal Cancer
R.G.C.C. - The Beljanski Foundation
PRESENTERS – Tripping Over the Truth Retreat
Ioannis Papasotiriou | RGCC International GmbH, Switzerland | Cancer Middle East 2015 | Conferenceseries
Under the auspices of H.E. the President of the Hellenic Republic ...
O3 Plus,LLC - With Dr Ioannis Papasotiriou, M.D., PhD, medical director of RGCC-Ltd. , Greece | Facebook
Journal for Clinical Studies by Pharma Publications - Issuu
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine
IPI - Volume 8 Issue 1 by Pharma Publications - Issuu
Ioannis PAPASOTIRIOU | Managing Director | Molecular Medicine
